Target intelligence / Profile preview

Influenza hemagglutinin protein stem region (HA stem region)

Target
HA stem region
Molecular classification
Viral fusion protein, Envelope glycoprotein, Class I fusion protein, Receptor (by function in virus entry)
01

Overview

The influenza hemagglutinin protein stem region is a highly conserved structural domain located at the base (proximal to the membrane) of the HA trimer, anchoring the globular head to the viral membrane. Hemagglutinin, the main surface glycoprotein of influenza A and B viruses, is critical for both viral attachment and membrane fusion during infection. The stem region, formed primarily by sequences from the HA2 subunit, harbors the molecular machinery necessary for fusion of the viral and cellular membranes after receptor-mediated endocytosis and exposure to low pH in the endosome[1][2][4]. This region is less variable than the head, making it the principal target for broadly neutralizing antibodies and the focus of universal influenza vaccine initiatives[1][10]. Broadly neutralizing antibodies, as well as small-molecule inhibitors and engineered binding proteins, can bind to the stem region and prevent the conformational changes required for fusion, thereby blocking viral entry and providing cross-strain protection[3][6][9][10]. Drugs directed at this region are under investigation, and the domain is increasingly recognized as a validated antiviral target.

Other names
Hemagglutinin stemHA stemInfluenza HA stemHemagglutinin stalkHA stalkInfluenza hemagglutinin stem
02

Mechanism of action

Inhibition of membrane fusion (by blocking structural rearrangement of the HA stem); Neutralization of viral infectivity by preventing conformational changes necessary for viral entry[3][6][10]; Promotion of antibody-dependent cell-mediated cytotoxicity and complement activation (for antibody drugs)[10]

03

Biological functions

Viral attachment to host cellMembrane fusion (viral and host cell membranes)Antigenic target for broadly neutralizing antibodies
04

Disease associations

Infection (influenza virus infection; role in viral entry and immune evasion)
05

Safety considerations

Antigenic variability and immune escape via drift in stem-adjacent regionsPotential for viral resistance to small-molecule inhibitors targeting the stem[6]Unknown long-term safety for novel biologics or small-molecule fusion inhibitors; immunopathology not fully characterized
06

Interacting drugs

Experimental stem-binding proteins (e.g., HB36.6)[3]

2 more in the full profile.

07

Biomarkers

Presence of anti-HA stem broadly neutralizing antibodies (used in vaccine research as a correlate of universal protection)[10]

Beyond the preview

Go deeper on Influenza hemagglutinin protein stem region (HA stem region).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza hemagglutinin protein stem region (HA stem region).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call